BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 15650412)

  • 1. The pulmonary biology of isoprostanes.
    Janssen LJ; Catalli A; Helli P
    Antioxid Redox Signal; 2005; 7(1-2):244-55. PubMed ID: 15650412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isoprostanes: an overview and putative roles in pulmonary pathophysiology.
    Janssen LJ
    Am J Physiol Lung Cell Mol Physiol; 2001 Jun; 280(6):L1067-82. PubMed ID: 11350785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isoprostanes and lung vascular pathology.
    Janssen LJ
    Am J Respir Cell Mol Biol; 2008 Oct; 39(4):383-9. PubMed ID: 18441279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pulmonary biology of isoprostanes.
    Janssen LJ
    Chem Phys Lipids; 2004 Mar; 128(1-2):101-16. PubMed ID: 15037156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. F2-isoprostanes as markers of oxidative stress in vivo: an overview.
    Milne GL; Musiek ES; Morrow JD
    Biomarkers; 2005 Nov; 10 Suppl 1():S10-23. PubMed ID: 16298907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isoprostanes: generation, pharmacology, and roles in free-radical-mediated effects in the lung.
    Janssen LJ
    Pulm Pharmacol Ther; 2000; 13(4):149-55. PubMed ID: 10930353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The isoprostanes: their role as an index of oxidant stress status in human pulmonary disease.
    Morrow JD; Roberts LJ
    Am J Respir Crit Care Med; 2002 Dec; 166(12 Pt 2):S25-30. PubMed ID: 12471085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Isoprostanes: new markers of oxidative stress in human diseases].
    Cracowski JL; Stanke-Labesque F; Souvignet C; Bessard G
    Presse Med; 2000 Mar; 29(11):604-10. PubMed ID: 10776418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isoprostanes: are they more than physiopathological biomarkers of lipid peroxidation?
    Cracowski JL; Baguet JP
    Circulation; 2003 Jun; 107(24):e222; author reply e222. PubMed ID: 12821598
    [No Abstract]   [Full Text] [Related]  

  • 10. Factors regulating isoprostane formation in vivo.
    Basu S; Helmersson J
    Antioxid Redox Signal; 2005; 7(1-2):221-35. PubMed ID: 15650410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. F2-isoprostanes biomarkers of lipid peroxidation: their utility in evaluation of oxidative stress induced by toxic agents.
    Piłacik B; Nofer TW; Wasowicz W
    Int J Occup Med Environ Health; 2002; 15(1):19-27. PubMed ID: 12038860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isoprostanes and phytoprostanes: Bioactive lipids.
    Durand T; Bultel-Poncé V; Guy A; El Fangour S; Rossi JC; Galano JM
    Biochimie; 2011 Jan; 93(1):52-60. PubMed ID: 20594988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The neurobiology of isoprostanes and Alzheimer's disease.
    Praticò D
    Biochim Biophys Acta; 2010 Aug; 1801(8):930-3. PubMed ID: 20116452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isoprostanes in fetal and neonatal health and disease.
    Belik J; González-Luis GE; Perez-Vizcaino F; Villamor E
    Free Radic Biol Med; 2010 Jan; 48(2):177-88. PubMed ID: 19854268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isoprostanes as biomarkers and mediators of oxidative injury in infant and adult central nervous system diseases.
    Greco A; Minghetti L
    Curr Neurovasc Res; 2004 Oct; 1(4):341-54. PubMed ID: 16181083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using isoprostanes as biomarkers of oxidative stress: some rarely considered issues.
    Halliwell B; Lee CY
    Antioxid Redox Signal; 2010 Jul; 13(2):145-56. PubMed ID: 20001743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Profiling of oxidized lipid products of marine fish under acute oxidative stress.
    Chung ML; Lee KY; Lee CY
    Food Chem Toxicol; 2013 Mar; 53():205-13. PubMed ID: 23220612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular pharmacology and physiology of the isoprostanes.
    Cracowski JL; Durand T
    Fundam Clin Pharmacol; 2006 Oct; 20(5):417-27. PubMed ID: 16968413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isoprostanes and hepatic fibrosis.
    Comporti M; Signorini C; Arezzini B; Vecchio D; Monaco B; Gardi C
    Mol Aspects Med; 2008; 29(1-2):43-9. PubMed ID: 18061254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. F2-isoprostanes in human health and diseases: from molecular mechanisms to clinical implications.
    Basu S
    Antioxid Redox Signal; 2008 Aug; 10(8):1405-34. PubMed ID: 18522490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.